Serving hundreds of leading biopharmaceutical companies globally:

Generated: December 16, 2018

DrugPatentWatch Database Preview

Drug Sales Trends for HYSINGLA ER

« Back to Dashboard

Payment Methods and Pharmacy Types for HYSINGLA ER (2016)

Revenues by Pharmacy Type

Chart
Table

Pharmacy Type	Revenues
MAIL-ORDER	$40,504,907
INSIDE ANOTHER STORE	$513,518,931
[disabled in preview]	$983,201,317
This preview shows a limited data set Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Chart
Table

Pharmacy Type	Units
MAIL-ORDER	154,599
INSIDE ANOTHER STORE	1,959,996
[disabled in preview]	3,852,782
This preview shows a limited data set Subscribe for full access, or try a Trial

Revenues by Payment Method

Chart
Table

Payment Method	Revenues
MEDICAID	$203,245,514
MEDICARE	$456,363,858
[disabled in preview]	$879,102,095
This preview shows a limited data set Subscribe for full access, or try a Trial

Drug Sales Revenue Trends for HYSINGLA ER

Drug Units Sold Trends for HYSINGLA ER

Annual Sales Revenues and Units Sold for HYSINGLA ER

These sales figures are drawn from a US national survey of drug expenditures

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Drug Name	Revenues (USD)	Units	Year
HYSINGLA ER	➤ Sign Up	➤ Sign Up	2016
HYSINGLA ER	➤ Sign Up	➤ Sign Up	2015
HYSINGLA ER	➤ Sign Up	➤ Sign Up	2014
HYSINGLA ER	➤ Sign Up	➤ Sign Up	2013
HYSINGLA ER	➤ Sign Up	➤ Sign Up	2012
HYSINGLA ER	➤ Sign Up	➤ Sign Up	2011
Drug Name	Revenues (USD)	Units	Year

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo

Queensland Health

Chubb

Citi

McKinsey

Covington

Moodys

US Department of Justice

Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.